Cargando…
Short-Term Neurodevelopmental Outcome in Term Neonates Treated with Phenobarbital versus Levetiracetam: A Single-Center Experience
BACKGROUND: Phenobarbital (PB) has been traditionally used as the first-line treatment for neonatal seizures. More recently, levetiracetam (LEV) has been increasingly used as a promising newer antiepileptic medication for treatment of seizures in neonates. OBJECTIVES: The aim of our study was to com...
Autores principales: | Falsaperla, Raffaele, Mauceri, Laura, Pavone, Piero, Barbagallo, Massimo, Vitaliti, Giovanna, Ruggieri, Martino, Pisani, Francesco, Corsello, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589264/ https://www.ncbi.nlm.nih.gov/pubmed/31281546 http://dx.doi.org/10.1155/2019/3683548 |
Ejemplares similares
-
Levetiracetam in Neonatal Seizures as First-line Treatment: A Prospective Study
por: Falsaperla, Raffaele, et al.
Publicado: (2017) -
Correspondence to Levetiracetam in Neonatal Seizures as First-Line Treatment
por: Falsaperla, Raffaele, et al.
Publicado: (2018) -
Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures
por: Maitre, Nathalie L, et al.
Publicado: (2013) -
Congenital muscular dystrophy: from muscle to brain
por: Falsaperla, Raffaele, et al.
Publicado: (2016) -
Pediatric Autoimmune Encephalitis
por: Barbagallo, Massimo, et al.
Publicado: (2017)